Edition:
India

Five Prime Therapeutics Inc (FPRX.OQ)

FPRX.OQ on NASDAQ Stock Exchange Global Select Market

6.66USD
19 Jun 2019
Change (% chg)

$0.13 (+1.99%)
Prev Close
$6.53
Open
$6.57
Day's High
$6.66
Day's Low
$6.42
Volume
10,290
Avg. Vol
102,950
52-wk High
$17.88
52-wk Low
$5.87

About

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering and developing protein therapeutics. The Company's product candidates include Cabiralizumab (FPA008), which is an antibody that inhibits colony stimulating factor-1 receptor, that it is studying in clinical trials as a monotherapy in... (more)

Overall

Beta: 4.21
Market Cap(Mil.): $1,122.56
Shares Outstanding(Mil.): 28.90
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates